Ashland Industries Europe GmbH

About Ashland Industries Europe GmbH

Who thinks outside the box to get more in it? We do.

Delivering pharmaceutical and nutraceutical performance, Ashland provides solutions for applications in tablet binding, film coating and disintegration, controlled-release formulation and drug solubilization. Ashland creates value for customers through bioavailability enhancement solutions, applications knowledge, market insight, regulatory support and a powerful product portfolio.


Our full line of products combined with our global research and development capabilities can help deliver your drugs when and where they're needed resulting in better outcomes for patients and pharmaceutical companies alike. As a full-service resource, Ashland can help you bind, coat, dissolve and deliver solutions that can yield better patient outcomes.

  • CH
  • 2015
    On CPhI since

Products from Ashland Industries Europe GmbH

  • Klucel™ hydroxypropylcellulose

    Product Klucel™ hydroxypropylcellulose

    Klucel™ hydroxypropylcellulose (HPC) is a nonionic water-soluble cellulose ether with a remarkable combination of properties. It combines organic solvent solubility, thermoplasticity and surface activity with the aqueous thickening and stabilizing properties characteristic of other water-soluble cellulose polymers available from Ashland. Klucel™ HPC films are flexible without plasticizers and non-tacky at high humidity. For more information visit https://www.ashland.com/industries/pharmaceutical/oral-solid-dose/klucel-hydroxypropylcellulose
  • Benecel™ methylcellulose and hypromellose

    Product Benecel™ methylcellulose and hypromellose

    Benecel™ products are high purity, water-souble, nonionic cellulose ethers.  Benecel™ hypromellose (hydroxypropyl-methylcellulose or HPMC) is a versatile excipient with a variety of applications.  HPMC is the most widely used polymer in hydrophilic matrix systems with widespread use in controlled-release dosage forms.  The Benecel™ family of pharmaceutical products, including Benecel™ XR and XRF HPMC, custom grades of Benecel™ HPMC, and Benecel™ DC HPMC, provides a full portfolio to support the controlled release of a broad range of APIs and manufacturing processes. For more information visit https://www.ashland.com/industries/pharmaceutical/oral-solid-dose/benecel-methylcellulose-and-hypromellose
  • Aquarius™ film coating systems

    Product Aquarius™ film coating systems

    Ashland's line of fully formulated, easily dispersed and ready-to-use Aquarius™ film coating systems have a range of functions to suit almost any core. With our wide selection of film coating choices, we can provide an optimal coating for your unique formulation. Aquarius™ Preferred film coating systems disperse easily in water. These film coatings are applicable to both pharmaceutical and nutraceutical solid dosage forms. Aquarius™ Prime film coating systems disperse easily in water and are applied to immediate-release dosage forms. Aquarius™ Control film coating systems consist of three types of coatings. Aquarius™ Control ENA film coating systems are delayed-release (enteric) coatings based on methacrylic acid copolymer. Aquarius™ Control SRX film coating systems are sustained-release coatings. Aquarius™ Control ECD is an aqueous dispersion of ethyl cellulose polymer for achieving controlled release, taste-masking, and moisture protection. To learn more visit https://www.ashland.com/industries/pharmaceutical/oral-solid-dose/aquarius-film-coating-systems
  • Aqualon™ ethylcellulose

    Product Aqualon™ ethylcellulose

    Aqualon™ ethylcellulose (EC) is a cellulose ether distinguished by its versatility. Aqualon™ EC is soluble in a wide range of organic solvents and is typically used as a non-swellable, insoluble component in matrix or coating systems. Aqualon™ EC can be used to coat one or more active ingredients of a tablet to prevent them from reacting with other materials or with one another. It can also be used on its own or in combination with water-soluble components to prepare sustained release film coatings that are frequently used for the coating of micro-particles, pellets and tablets. To learn more visit https://www.ashland.com/industries/pharmaceutical/oral-solid-dose/aqualon-ethylcellulose

  • Aqualon™ sodium carboxymethylcellulose

    Product Aqualon™ sodium carboxymethylcellulose

    Aqualon™ CMC are anionic, water-soluble cellulose ethers, produced by reacting alkalicellulose with monochloroacetic acid under controlled conditions. Aqualon™ CMC is available in a variety of grades with different degrees of substitution,viscosity and particle size to meet specific formulation requirements are available. Ashland provides CMC under the tradenames Aqualon™ CMC and Blanose™ CMC depending on site of manufacture.  To learn more visit https://www.ashland.com/industries/pharmaceutical/oral-solid-dose/aqualon-sodium-carboxymethylcellulose
  • Blanose™ sodium carboxymethylcellulose

    Product Blanose™ sodium carboxymethylcellulose

    Blanose™ CMC are anionic, water-soluble cellulose ethers, produced by reacting alkalicellulose with monochloroacetic acid under controlled conditions. Blanose™ CMC is available in a variety of grades with different degrees of substitution,viscosity and particle size to meet specific formulation requirements are available. Ashland provides CMC under the tradenames Aqualon™ CMC and Blanose™ CMC depending on site of manufacture.  To learn more visit https://www.ashland.com/industries/pharmaceutical/oral-solid-dose/blanose-sodium-carboxymethylcellulose
  • Cavamax* native cyclodextrins

    Product Cavamax* native cyclodextrins

    The molecular structure of cyclodextrins creates a bucket-like cavity that can complex with molecules or functional groups on molecules to improve solubility of poorly soluble compounds. The same mechanism makes these excipients capable of masking unpleasant taste/odor and stabilizing drugs that are prone to degradation. Cavamax* native cyclodextrins are biocompatible and compatible with a wide range of ingredients commonly used in pharmaceutical applications. To learn more visut https://www.ashland.com/industries/pharmaceutical/oral-solid-dose/cavamax-native-cyclodextrins
  • Cavitron™ and Cavasol* hydroxypropyl-ß- and hydroxypropyl-?-cyclodextrins (HPBCD and HPGCD)

    Product Cavitron™ and Cavasol* hydroxypropyl-ß- and hydroxypropyl-?-cyclodextrins (HPBCD and HPGCD)

    The molecular structure of cyclodextrins creates a bucket-like cavity that can function to complex with molecules or functional groups on molecules. The substitution of hydroxyl groups on native cyclodextrins to make hydroxypropyl-ß- or hydroxypropyl-γ-cyclodextrins (HPBCD or HBGCD) significantly enhances their solubility and makes them more suitable for drug solubilization. This mechanism makes the Cavitron™ and CAVASOL* HPBCDs and HPGCDs capable of masking unpleasant taste/odor and stabilizing drugs that are prone to degradation, and also can increase solubility of poorly soluble compounds in oral drug delivery systems. Purification of the Cavitron™ cyclodextrins to remove endotoxins allows their use for solubilization of drugs for parenteral drug products. To learn more visit https://www.ashland.com/industries/pharmaceutical/oral-solid-dose/cavitron-cyclodextrin-and-cavasol-cyclodextrin
  • Ferronyl™ iron supplement

    Product Ferronyl™ iron supplement

    Ferronyl™ iron supplement isan ideal source of essentially pure iron with low toxicity,minimal metallic taste andexcellent bioavailability. Ferronyl™ iron supplement is elemental iron (Fe) with high (> 98%) iron content,manufactured by the chemical decomposition of iron pentacarbonyl. The resulting iron particles are small, uniform spheres of high purity, with only traces of carbon, oxygen and nitrogen. High iron content results in lower use levels to achieve the same daily intake levels compared with ferrous(Fe2+) salts.
  • Natrosol™ hydroxyethylcellulose

    Product Natrosol™ hydroxyethylcellulose

    Natrosol™ 250 hydroxyethylcellulose (HEC) is a nonionic, water-soluble cellulose ether. Natrosol™ 250 HEC is easily dispersed in cold or hot water to give solutions of varying viscosities and desired properties, though it is insoluble in organic solvents. It is used in solutions and gels to control rheology, in emulsions for high-salt tolerance and surfactant compatibility and in modified-release matrix tablets, where high-viscosity grades provide effective diffusion-limiting release of active pharmaceutical ingredients (API) with low water solubility.
  • Pharmasolve™ N-methyl-2-pyrrolidone

    Product Pharmasolve™ N-methyl-2-pyrrolidone

    Pharmasolve™ N-methyl-2-pyrrolidone (NMP) is a versatile solubilizer for one-component systems. It is a water-miscible polar aprotic solvent with high interfacial activity. Pharmasolve™ NMP is manufactured in a facility with ISO 9001:2015 and EXCiPACT GMP certifications. It is used as a drug solubilizer and penetration enhancer in human and animal parenteral dosage forms.
  • Plasdone™ povidone

    Product Plasdone™ povidone

    Plasdone™ povidones are a family of water-soluble polymers based on N-vinylpyrrolidone that combine a unique set of properties for application in a wide variety of dosage forms. Plasdone™ povidones are commonly used as binders for the development of tablet formulations, whether manufactured by wet granulation, dry granulation or direct compression.  To learn more visit https://www.ashland.com/industries/pharmaceutical/oral-solid-dose/plasdone-povidone

Ashland Industries Europe GmbH Resources